Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

Similar articles for PubMed (Select 19798508)

1.

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery.

Bordeianou L, Kunitake H, Shellito P, Hodin R.

Int J Colorectal Dis. 2010 Mar;25(3):401-4. doi: 10.1007/s00384-009-0800-5. Epub 2009 Oct 2.

PMID:
19798508
2.

Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.

Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L.

J Gastrointest Surg. 2008 Oct;12(10):1730-6; discussion 1736-7. doi: 10.1007/s11605-008-0630-8. Epub 2008 Aug 16.

PMID:
18709514
3.

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.

Jakobovits SL, Jewell DP, Travis SP.

Aliment Pharmacol Ther. 2007 May 1;25(9):1055-60.

4.

Colectomy rate in acute severe ulcerative colitis in the infliximab era.

Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R.

Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9.

PMID:
18472316
5.

Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?

Schluender SJ, Ippoliti A, Dubinsky M, Vasiliauskas EA, Papadakis KA, Mei L, Targan SR, Fleshner PR.

Dis Colon Rectum. 2007 Nov;50(11):1747-53.

PMID:
17704969
6.

A review of infliximab use in ulcerative colitis.

Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Review.

PMID:
18343261
7.

Infliximab and complications after colectomy in patients with ulcerative colitis.

Bregnbak D, Mortensen C, Bendtsen F.

J Crohns Colitis. 2012 Apr;6(3):281-6. doi: 10.1016/j.crohns.2011.08.014. Epub 2011 Sep 25.

PMID:
22405163
8.

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.

Seow CH, Newman A, Irwin SP, Steinhart AH, Silverberg MS, Greenberg GR.

Gut. 2010 Jan;59(1):49-54. doi: 10.1136/gut.2009.183095. Epub .

PMID:
19651627
9.

A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.

Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, Boulton-Jones R, Williams A, Church N, Satsangi J, Arnott ID; Scottish Society of Gastroenterology Infliximab Group.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):411-9.

10.

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B.

Gastroenterology. 2005 Jun;128(7):1805-11.

PMID:
15940615
11.

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study.

Gornet JM, Couve S, Hassani Z, Delchier JC, Marteau P, Cosnes J, Bouhnik Y, Dupas JL, Modigliani R, Taillard F, Lemann M.

Aliment Pharmacol Ther. 2003 Jul 15;18(2):175-81.

12.

Infliximab efficacy in pediatric ulcerative colitis.

Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M.

Inflamm Bowel Dis. 2005 Mar;11(3):213-8.

PMID:
15735427
13.

Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy.

Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH.

Dis Colon Rectum. 2008 Aug;51(8):1202-7; discussion 1207-10. doi: 10.1007/s10350-008-9364-7. Epub 2008 Jun 7.

PMID:
18536964
14.

Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.

Yamamoto-Furusho JK, Uzcanga LF.

Dig Surg. 2008;25(5):383-6. doi: 10.1159/000170882. Epub 2008 Nov 13.

PMID:
19005257
15.

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.

Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck CD, Sandborn WJ.

Am J Gastroenterol. 2004 May;99(5):878-83.

PMID:
15128354
16.

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK.

Inflamm Bowel Dis. 2001 May;7(2):83-8.

PMID:
11383595
17.

Infliximab for hospitalized patients with severe ulcerative colitis.

Regueiro M, Curtis J, Plevy S.

J Clin Gastroenterol. 2006 Jul;40(6):476-81.

PMID:
16825928
18.

Infliximab for treatment of steroid-refractory ulcerative colitis.

Actis GC, Bruno M, Pinna-Pintor M, Rossini FP, Rizzetto M.

Dig Liver Dis. 2002 Sep;34(9):631-4.

PMID:
12405249
19.

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.

Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):747-56.

20.

Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.

Russo EA, Harris AW, Campbell S, Lindsay J, Hart A, Arebi N, Milestone A, Tsai HH, Walters J, Carpani M, Westaby D, Thillainayagam A, Bansi D, Ghosh S.

Aliment Pharmacol Ther. 2009 Feb 1;29(3):308-14. doi: 10.1111/j.1365-2036.2008.03890.x. Epub 2008 Nov 13.

PMID:
19035973
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk